Additional information
| Active substance | Tamoxifen Citrate | 
|---|---|
| Active Half-Life | 5-7 days | 
| Classification | SERM | 
| Dosage | 20-40 mg/day | 
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | Monitoring liver function tests is recommended | 
| Also known as | TAM, tamoxifen citrate | 
| WAREHOUSE | International Warehouse 1 | 
| Blood pressure | Little to no effect on blood pressure | 
| Trade name | Nolvadex, Soltamox | 
| Storage conditions | Store at room temperature away from moisture and heat | 
| Chemical name | (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine | 
| Formula | C26H29NO | 
| Substance class | Selective Estrogen Receptor Modulator (SERM) | 
| Main action | Estrogen receptor antagonist | 
| Half-life | 5 to 7 days | 
| Dosage (medical) | 20 mg daily | 
| Dosage (sports) | 10-20 mg daily | 
| Effects | Reduces the effect of estrogen in the body, can stimulate ovulation | 
| Side effects | Hot flashes, vaginal discharge, menstrual irregularities, increased risk of endometrial cancer, cataracts, and thromboembolic events such as deep vein thrombosis and pulmonary embolism | 
| Use in sports | Used to counteract the side effects of anabolic steroids, specifically gynecomastia | 
| Manufacturer | Cipla | 
 Femara Aaster Health and Sports Solutions
							Femara Aaster Health and Sports Solutions						 Tamoxifen 20 Aaster Health and Sports Solutions
							Tamoxifen 20 Aaster Health and Sports Solutions						 Tamoxifen 20 mg Ice Pharmaceuticals
							Tamoxifen 20 mg Ice Pharmaceuticals						

 
			 
			 
			 
			
Reviews
There are no reviews yet.